Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity.

Diabetes Obes Metab · 2018 · PMC5836914 · PMID 28941314

Europe PMC DOI

hedged sentence

0.0569

closest p · 1.1× alpha

0.0569

boldest claim

The sentences

borderline significantP = .0569so close (0.05 < p ≤ 0.1)

Before the fat‐rich breakfast, subjects treated with semaglutide also had higher fasting concentrations of insulin and C‐peptide, although this was only borderline significant for insulin (ETR: 1.18 [95% CI: 0.99, 1.41]; P = .0569; and ETR: 1.23 [95% CI: 1.09, 1.38]; P = .0012, respectively, Table 1 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.